TRNS News Alert Transcat Inc (TRNS) 9.80 12/25/2014 17:14:17

New Post Public Reply Private Reply Replies (0) Message Board

Dec 25, 2014 at 6:14 PM

Transcat Inc (TRNS) 9.80 $TRNS

Where Companies are Headed: Exclusive Report on TeleNav, Tesla, ExOne, THT and Transcat
PR Newswire - Wed Dec 24, 7:20AM CST
Moments ago, Analysts Review released new research updates concerning several important developing situations including TeleNav (NASDAQ: TNAV), Tesla (NASDAQ: TSLA), ExOne (NASDAQ: XONE), THT (NASDAQ: THTI), and Transcat (NASDAQ: TRNS). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.
TRNS: 9.80 (-0.10), TSLA: 222.26 (+1.29), TNAV: 6.53 (+0.13), XONE: 15.32 (+0.25), THTI: 1.32 (+0.14)

Small Cap Profiles: OPXA, NEWC, TRNS, MLER
ACCESSWIRE - Thu Dec 11, 9:35AM CST
WHITEFISH, MT / ACCESSWIRE / December 11, 2014 /
TRNS: 9.80 (-0.10), BIIB: 340.89 (+5.13), OPXA: 0.80 (+0.01), SNY: 46.35 (+0.50)

Insider Trading Alert - CRK, ETH And TRNS Traded By Insiders
at The Street - Tue Dec 02, 10:00AM CST
Stocks with insider trader activity include CRK, ETH and TRNS
TRNS: 9.80 (-0.10), ETH: 30.28 (-0.08), CRK: 7.01 (-0.20)

Transcat Launches New Web 3.0 Platform
GlobeNewswire - Mon Dec 01, 1:00PM CST
Transcat, Inc. (Nasdaq:TRNS) ("Transcat" or the "Company"

, a leading provider of accredited calibration and compliance services and distributor of professional grade handheld test, measurement and control instrumentation, announced today that it has launched Web 3.0, a new website platform designed to support both segments of Transcat's business.
TRNS: 9.80 (-0.10)

Nasdaq stocks posting largest volume decreases
AP - Tue Nov 25, 5:58PM CST
NEW YORK (AP) — A look at the 10 biggest volume decliners on Nasdaq at the close of trading:
SIBC: 15.93 (-0.07), TRNS: 9.80 (-0.10), OFED: 19.01 (unch), COBK: 13.39 (unch), GRIF: 30.05 (+0.01), OVBC: 24.20 (-0.04), SONA: 11.29 (unch), SLTC: 5.51 (-0.09), SMBC: 37.01 (+0.01), UCBA: 11.56 (-0.36), MGYR: 8.40 (+0.02)

Insider Trading Alert - ABTL, TRNS And MGPI Traded By Insiders
at The Street - Fri Nov 21, 12:15PM CST
Stocks with insider trader activity include ABTL, TRNS and MGPI
TRNS: 9.80 (-0.10), ABTL: 11.24 (-0.04), MGPI: 16.53 (+0.28)

Transcat's Services Segment Reaches Inflection Point, Management Continues To Agressively Pursue Its Growth
Bram de Haas - Seeking Alpha - Fri Nov 21, 11:02AM CST
Transcat (NASDAQ: TRNS ) is a distributor of test and measurement instruments. This is mostly a B2B market. The company is also an accredited provider of calibration, inspection, engineering and repair services of test & measurement instruments. ...
TRNS: 9.80 (-0.10)

Transcat (TRNS) Upgraded From Hold to Buy
at The Street - Mon Nov 17, 8:21AM CST
Transcat (TRNS) has been upgraded by TheStreet Ratings from Hold to Buy with a ratings score of B.
TRNS: 9.80 (-0.10)

Transcat's (TRNS) CEO Lee Rudow on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Oct 28, 9:41PM CDT

TRNS: 9.80 (-0.10)

Transcat EPS $0.12
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 3:25PM CDT

TRNS: 9.80 (-0.10)

Transcat Reports Fiscal 2015 Second Quarter Record Revenue of $31.1 Million; Earnings per Diluted Share Up 20%
GlobeNewswire - Mon Oct 27, 3:09PM CDT
-- Second quarter consolidated operating income grew 18.3% on 7.7% revenue growth
TRNS: 9.80 (-0.10)

Transcat Announces Second Quarter Fiscal Year 2015 Conference Call and Webcast
GlobeNewswire - Tue Oct 14, 5:55AM CDT
Transcat, Inc. (Nasdaq:TRNS) ("Transcat" or the "Company"

, a leading provider of accredited calibration and compliance services and distributor of professional grade handheld test, measurement and control instrumentation, announced today that it will release its second quarter fiscal year 2015 results after the close of financial markets on Monday, October 27, 2014.
TRNS: 9.80 (-0.10)

Transcat, Inc. to Present at the 2014 Western New York Investors Conference
GlobeNewswire - Tue Sep 16, 3:37PM CDT
Transcat, Inc. (Nasdaq:TRNS) ("Transcat" or the "Company"

, a leading provider of accredited calibration and compliance services and distributor of professional grade handheld test, measurement and control instrumentation, announced today that Lee D. Rudow, President and Chief Executive Officer, and John J. Zimmer, Senior Vice President of Finance and Chief Financial Officer, will present to institutional investors and analysts at the 2014 Western New York Investors Conference on Friday, September 26, 2014 in Buffalo, New York.
TRNS: 9.80 (-0.10)

Nasdaq stocks posting largest percentage decreases
AP - Fri Sep 12, 12:20PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
TRNS: 9.80 (-0.10), EFOI: 5.10 (+0.01), EOPN: 9.37 (-0.02), AKAO: 12.76 (-0.23), TIPT: 7.94 (+0.14), HCCI: 11.76 (-0.41), ISNS: 2.77 (+0.04), MNDL: 3.22 (+0.08), STML: 15.53 (+0.23), OREX: 5.98 (+0.01), CROX: 12.37 (+0.04), ECYT: 6.33 (+0.24), SCYX: 10.49 (+0.65), FLXS: 32.00 (-0.18), PEIX: 11.15 (+0.37)

Transcat Acquires Ulrich Metrology Inc. and Expands Reach in Canada
GlobeNewswire - Fri Aug 29, 8:06AM CDT
Transcat, Inc. (Nasdaq:TRNS) ("Transcat" or the "Company"

, a leading Canadian provider of accredited and commercial calibrations with annualized revenue of $3.7 million. Founded in 1976 and headquartered in Montreal, Ulrich specializes in providing custom metrology solutions for the aerospace and defense, industrial manufacturing and life science industries. Ingrid Ulrich, President of Ulrich, and Ronald Barry, General Manager, will be remaining with Transcat.
TRNS: 9.80 (-0.10)

Transcat Increases Secured Revolving Credit Facility
GlobeNewswire - Tue Aug 26, 3:08PM CDT
Transcat, Inc. (Nasdaq:TRNS) ("Transcat" or the "Company"

, a leading provider of accredited calibration and compliance services and distributor of professional grade handheld test, measurement and control instrumentation, announced today that it has executed an amendment to its $20 million secured revolving credit agreement, increasing the funds available under the amended credit facility to $30 million. The amended credit facility matures on September 20, 2018.
TRNS: 9.80 (-0.10)

Transcat Agrees to Terms on $1.5 Million Calibration and Compliance Services Contract
GlobeNewswire - Thu Jul 31, 3:13PM CDT
Transcat, Inc. (Nasdaq:TRNS) ("Transcat" or the "Company"

, a leading provider of accredited calibration and compliance services and distributor of professional grade handheld test, measurement and control instrumentation, announced today that the Company has agreed to terms on a three-year, $1.5 million contract to provide calibration and compliance services to a Life Science company headquartered in the Northeast U.S. The customer specializes in digital diagnostic tools and services to assist in better health decisions.
TRNS: 9.80 (-0.10)

Transcat Inc. to Present at the Jefferies 2014 Global Industrials Conference
GlobeNewswire - Thu Jul 31, 5:54AM CDT
Transcat, Inc. (Nasdaq:TRNS), a leading provider of accredited calibration and compliance services and distributor of professional grade handheld test, measurement and control instrumentation, announced today that Lee D. Rudow, President and Chief Executive Officer, and John J. Zimmer, Senior Vice President of Finance and Chief Financial Officer, will present at the Jefferies 2014 Global Industrials Conference in New York City on August 14, 2014.
TRNS: 9.80 (-0.10)

Transcat Reports Modest Revenue Growth Driven by the Service Segment for Fiscal 2015 First Quarter
GlobeNewswire - Tue Jul 29, 3:11PM CDT
-- Service segment 3.4% organic revenue growth
TRNS: 9.80 (-0.10)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

AppLovin Legal Woes: A Deep Dive into Investor Claims

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Microsoft's Cloud Misstep: Recovery Plans in Focus

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

EFICYENT Ventures to Connect at Singapore FinTech Fest

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Maritime Safety Urged After New Orleans Vessel Incident

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Windward Bio Surges 68% in Nasdaq Debut

By Ryan Hughes Updated Nov 13, 2026 Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...